Giotto Biotech is one of the winning companies of Faber 2. Thanks to this funding, a new resource will become part of our team and will develop a research project addressed to the Italian agro-food companies. The project intends to apply nuclear magnetic resonance (NMR) based metabolomics for the determination of the quality and the geographic characterization of agro-food product.

Faber 2 is a project of the di Fondazione CR Firenze, Confindustria Firenze and Fondazione per la Ricerca e l’Innovazione, promoted by Università degli Studi di Firenze and Città Metropolitana di Firenze.

A project of

In cooperation with

Sep 23-25, 2019 at Convitto della Calza in Florence, Italy.

International conference New Frontiers in Structure-Based Drug Discovery,

Attracting a high-level audience of researchers, the conference will provide a stimulating platform to discuss with academic experts and scientists from biotech and pharmaceutical industries. Topics include innovative screens on protein-protein interactions, novel targets and target validation, structure-based drug discovery, computational approaches and more. The conference will provide a valuable platform to discuss the challenges and opportunities of modern drug discovery in academia and industry.

For more info and registrations click here

 

 

The first RNAct meeting was held in Brussels. Tommaso Martelli and Marco Fragai, as Giotto Biotech reference people for the network, met with the other partners to start the project (Vrije Universiteit Brussel, Centre National de la Recherche Scientifique, Helmholtz Zentrum Muenchen, Consejo Superior de Investigaciones Cientificas, Dynamic Biosensors GmbH, Ridgeview Instruments AB).

If you want to participate in our RNAct training network, you can apply for one of the open positions until March 15, 2019.

More information on the project can be found at http://rnact.eu
Applications must be submitted online at https://tinyurl.com/rnact-eu

Congratulations to Alessia Vignoli! She won the two-years AIRC fellowship “Eduardo Spinnato”.”METabolomic profile as a prognostic biomarker of risk of recurrence in patients operated for COLon cancer (METCOL)” is the title of her research project. The project will be carried on thanks to a strict collaboration between Cerm (Prof. Claudio Luchinat research team) and the Medical Oncology Department at Hospital of Prato (Dr. Angelo Di Leo equipe).
 

Maxime Denis, Giotto Biotech’s PhD student, presented his reasearch progress on “Design and optimization of paramagnetic tags for NMR”. His presentation was held in Paris at 5th AEGIS Training school.

Social media & sharing icons powered by UltimatelySocial

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close